| Synonyms: | |
| Status: | Phase 3 |
| Entry Type: | Antibody |
| Molecule Category: | UNKNOWN |
| UNII: | IBS1BZ4E4I |
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | Programmed cell death protein 1 inhibitor |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Hodgkin Disease | 3 | D006689 | ClinicalTrials |
| Carcinoma, Squamous Cell | 3 | D002294 | ClinicalTrials |
| Carcinoma, Hepatocellular | 3 | D006528 | ClinicalTrials |
| Lung Neoplasms | 3 | D008175 | ClinicalTrials |
| Carcinoma, Squamous Cell | 3 | D002294 | ClinicalTrials |
| Hodgkin Disease | 3 | D006689 | ClinicalTrials |
| Nasopharyngeal Carcinoma | 3 | D000077274 | ClinicalTrials |
| Stomach Neoplasms | 2 | D013274 | ClinicalTrials |
| Glioblastoma | 2 | D005909 | ClinicalTrials |
| Lymphoma, Large B-Cell, Diffuse | 2 | D016403 | ClinicalTrials |
| Small Cell Lung Carcinoma | 2 | D055752 | ClinicalTrials |
| Essential Tremor | 2 | D020329 | ClinicalTrials |
| Pancreatic Neoplasms | 2 | D010190 | ClinicalTrials |
| Breast Neoplasms | 2 | D001943 | ClinicalTrials |
| Esophageal Neoplasms | 2 | D004938 | ClinicalTrials |
| Thyroid Neoplasms | 2 | D013964 | ClinicalTrials |
| Uterine Cervical Neoplasms | 2 | D002583 | ClinicalTrials |
| Colorectal Neoplasms | 2 | D015179 | ClinicalTrials |
| Neoplasms | 2 | D009369 | ClinicalTrials |
| Pancreatic Neoplasms | 2 | D010190 | ClinicalTrials |
| Rectal Neoplasms | 2 | D012004 | ClinicalTrials |
| Stomach Neoplasms | 2 | D013274 | ClinicalTrials |
| Neoplasms | 2 | D009369 | ClinicalTrials |
| Breast Neoplasms | 2 | D001943 | ClinicalTrials |
| Nasopharyngeal Neoplasms | 2 | D009303 | ClinicalTrials |
| Pheochromocytoma | 2 | D010673 | ClinicalTrials |
| Paraganglioma | 2 | D010235 | ClinicalTrials |
| Carcinoma, Non-Small-Cell Lung | 2 | D002289 | ClinicalTrials |
| Lymphoma | 1 | D008223 | ClinicalTrials |
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL4297571 |
| FDA SRS | IBS1BZ4E4I |